Gujarat Kidney And Superspeciality Limited has announced a key management change with the resignation of its Company Secretary and Compliance Officer. The company informed stock exchanges about this development in compliance with regulatory requirements.

Key Personnel Change

Mrs. Niki Paresh Tiwari has tendered her resignation from the position of Company Secretary and Compliance Officer with immediate effect. The resignation was submitted on March 2, 2026, citing the pursuit of career opportunities outside the organization.

Management Response

The company management has accepted the resignation and established March 27, 2026, as the official relieving date. This provides a transition period of approximately 25 days from the resignation submission date.

Succession Planning

Gujarat Kidney And Superspeciality Limited has commenced the process of identifying and shortlisting potential candidates for the Company Secretary role. The company has committed to finalizing the appointment within the prescribed timelines under the SEBI (Listing Obligations and Disclosure Requirements) Regulations.

The company will make the required disclosure regarding the new appointment at the appropriate time, ensuring compliance with regulatory requirements.

Regulatory Compliance

The resignation notification was submitted to both BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. This ensures proper disclosure to stakeholders and maintains transparency in corporate governance practices.

The company operates from its registered office at Plot No.1, City Survey No 1537/A, Gokak Mill Compound, Jetalpur Road, Alkapuri, Vadodara, Gujarat, and maintains NABH accreditation for its healthcare services.

Gujarat Kidney And Super Speciality Limited announced significant expansion moves as its board of directors approved two major acquisitions during a meeting held on January 6, 2026. The healthcare company has decided to acquire the remaining 49% equity stake in Harmony Medicare Private Limited and make a substantial payment for its previously acquired Ashwini Medical Centre.

Harmony Medicare Acquisition Details

The board approved the purchase of the remaining 49% equity stake in Harmony Medicare Private Limited for ₹107.80 crores through cash consideration. This strategic acquisition will convert Harmony Medicare into a wholly owned subsidiary of Gujarat Kidney And Super Speciality Limited.

Harmony Medicare Private Limited, incorporated on June 16, 2009, operates as a medical and healthcare service provider with its registered office in Bharuch, Gujarat. The company has demonstrated consistent growth over the past three years.

The target company maintains an authorized share capital of ₹10.00 crores and paid-up capital of ₹10.00 crores, comprising 10,00,000 equity shares of ₹10 each.

Ashwini Medical Centre Payment Approval

In accordance with the acquisition agreement and IPO objectives, the board approved a part payment of ₹124.00 crores as purchase consideration for the already acquired Ashwini Medical Centre. This partnership firm, established on April 22, 2004, in Anand, Gujarat, provides medical and pharmacy services.

Ashwini Medical Centre has shown stable performance with the following turnover figures:

Strategic Impact and Regulatory Compliance

Both acquisitions align with Gujarat Kidney And Super Speciality Limited's strategy to strengthen its presence in the healthcare sector and diversify its business portfolio. The Harmony Medicare acquisition represents a related party transaction conducted at arm's length, while the Ashwini Medical Centre acquisition does not involve related parties.

Neither acquisition requires governmental or regulatory approvals, and both transactions are expected to complete within approximately two months. The company has fulfilled all disclosure requirements under Regulation 30 of SEBI Listing Regulations, providing comprehensive details in the annexures to its board meeting outcome.